As a Boston-based crypto analyst with a CFA and blockchain security certification, I’ve watched Eyenovia’s transformation from near-bankrupt biotech firm to a DeFi front-runner. This isn’t just hype—it’s strategy. With 5000万美元 in PIPE funding and a plan to stake over 1 million HYPE tokens, the company is building what could become the first institutional-grade HyperStrategy. Let’s break down the math, the mechanics, and why this might be more than just an asset play.